These sEVs are internalized by HCC cells to downregulate androgen receptor (AR) expression, activating the AR/PHLPP/p-AKT/β-catenin signaling axis and promoting tumor progression. The gene discussed is PHLPP1; the disease is hepatocellular carcinoma.